🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Former OPC fellow, Med Toxicologist & Historian, Adam Blumenberg, MD just gave a knockout presentation on the early 1900s use of Radithor in his Toxic History of Quack & Sham Tx lecture @ #NACCT23. Visit toxichistory.com for more tox history by Adam Blumenberg MD! ☠️ @OSHUTox

This was so amazing! Thank you Kate Moore (author of The Radium Girls) for joining us at our first AACT Book Club!

Can you say…AWESOME??? #NACCT2023

When you’re at a toxicology conference trying to “one-up” a colleague with your crazy case then, they drop this… #NACCT2023 #MedTwitter #TwitteRx

Thanks everyone for a wonderful #NACCT2023!! We will see you next year :) ☠️ 🍄

➡️bit.ly/statementnalma…⬅️READ NOW: Joint American College of Medical Toxicology/AACT statement published in Journal of Medical Toxicology + Clinical Toxicology : "Nalmefene should not replace naloxone as the primary opioid antidote at this time" 🧵 Andrew Stolbach, MD, MPH Maryann Amirshahi Lewis Nelson

1/3 #Nalmefene is a potent, long-acting #opioid antagonist that has recently been reintroduced in the U.S. (after being withdrawn in 2008) to treat known or suspected opioid #overdose by IN and injection routes

2/3 As #nalmefene is untested in current clinical envirnmt of synthetic #opioid #overdoses and has potential to cause harm via prolonged withdrawal, it is the opinion of American College of Medical Toxicology and @aactinfo that nalmefene shouldn't replace naloxone as primary opioid antidote at this time

3/3 We recommend additional clinical studies of #nalmefene, administered via all approved routes, be conducted in a comparative fashion with #naloxone, and that safety and effectiveness outcomes be evaluated before nalmefene is recommended as a primary #opioid antidote.

Looking for an international speaking opportunity? Present a challenging toxicology case for an expert panel during at the #NACCT2024 NACCT in Denver. A great opportunity for fellows! Submit by April 1, 2024. Don't miss out! Submit here: forms.gle/4VpFsiHa4aU8Nm…

Submit today! CPC Submission Deadline: June 3, 2024 acmt.net/acmt-at-2024-n…

Fellow in Training Board of Trustees Position Opportunity - mailchi.mp/clintox/fitbot…

Submit a Question of the Day - mailchi.mp/e55d610d5381/q…

Fellow in Training Board of Trustees Position Opportunity - mailchi.mp/clintox/fitbot…

Contact Us! - mailchi.mp/598eea531dc2/q…

NEXT WEEK—Learn about the pathophysiology and historical significance of cardiac biomarkers in toxicology and more at the AACT Section Webinar! Don't miss out, and secure your spot now before it's too late: buff.ly/LijIvUj

TOMORROW—Learn about the pathophysiology and historical significance of cardiac biomarkers in toxicology and more at the AACT Section Webinar! Don't miss out, and register now before it's too late: buff.ly/LijIvUj

DUE TOMORROW—Submit your symposium proposals for #NACCT2025 before it's too late! Don't miss out on your opportunity to exercise your skills and share your knowledge with others in the field of clinical toxicology. Learn more + submit here: buff.ly/zVgwXBt

LAST CHANCE to submit your symposium proposals for #NACCT2025! Submissions are due by 11:59 PM ET to be considered. Don't miss out on your opportunity to exercise your skills and share your knowledge. Hurry, before it's too late: buff.ly/zVgwXBt

Don't forget to register for July's AACT Book Club! The book of the month will be Fentanyl, Inc. by Ben Westhoff. Join us virtually on July 8 at 1 PM ET to learn more: buff.ly/cVnW0nj